Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
07/2008
07/23/2008CN100404548C Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
07/23/2008CN100404533C New quinuclidine amide derivatives
07/23/2008CN100404531C Xylylene imide herbicide
07/23/2008CN100404505C Novel substituted indoles
07/23/2008CN100404479C Method for producing aromatic unsaturated compound
07/22/2008US7402698 1-[2-(benzylamino)-1-(3,4-dichlorophenyl)ethyl]cyclobutanol hydrochloride; norepinephrine reuptake inhibitor; antidepressant, analgesic; vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, sleep disorder, hormone replacement syndrome
07/22/2008US7402696 exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hyperten
07/22/2008US7402682 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates
07/22/2008US7402681 Compound with indolocarbazole moieties and devices containing such compound
07/22/2008US7402677 used to label biological molecules such as proteins, polypeptides, amino acids, nucleic acids, and nucleotides, in clothing dyes, and in cosmetics; use in multiplex detection
07/22/2008US7402675 Process for the synthesis of amine ethers from secondary amino oxides
07/22/2008US7402604 4-oxy- or amino-substituted indole-2-carboxy acids, esters and amides, e.g., N-(2-hydroxy-1-phenylethyl) 4-hydroxy-1-methyl-1H-indole-2-carboxamide; nicotinic receptor agonist; conditions associated with reductions in nicotinic transmission; Alzheimer's disease, anxiety or schizophrenia
07/22/2008CA2481246C Compounds that modulate ppar activity and methods for their preparation
07/17/2008WO2008084499A1 An industrial process for the preparation of pure ropinirole
07/17/2008WO2008084494A1 Novel polymorphic forms of carvedilol dihydrogen phosphate and process for preparing the same
07/17/2008WO2008084492A1 5-(heterocyclyl)alkyl-n-(arylsulfonyl)indole compounds and their use as 5-ht6 ligands
07/17/2008WO2008084491A1 4-(heterocyclyl)alkyl-n-(arylsulfonyl) indole compounds and their use as 5-ht6 ligands
07/17/2008WO2008029349A3 Muscarinic receptor antagonists
07/17/2008WO2008002683A3 Polymorphous forms of carvedilol phosphate
07/17/2008US20080171885 Process for Preparation of Highly Pure Trandolapril
07/17/2008US20080171884 Novel Polymorph Form G of Fluvastatin Sodium and Process For the Preparation Thereof
07/17/2008US20080171873 Converting a chiral epoxyester or epoxycarboxamide to a chiral primary epoxyamine with an alkali hypohalite; reducing to form the amine;2-benzyl-4-methyl-4-phenyl-(1-oxo-1,3-dihydroisobenzofuran-5-yl)amino-pentan-2-ol; 4-methyl-2,4-diphenyl-(1-oxo-1,3-dihydroisobenzofuran-5-yl)amino-pentan-2-ol
07/17/2008US20080171788 N-(diaminomethylene)-9H-fluorene-2-carboxamide derivatives; dual antagonist for 5-HT2B and 5-HT7 receptors having selective binding affinities for 5-HT2B and 5-HT7 receptors; side effect reduction, nontoxic
07/17/2008US20080171782 2-[5-(3-Methylphenyl)-1-octyl-1H-indol-3-yl]acetamide (cysmethynil) and derivatives; anticarcinogenic agents; leukemia; antiinflammatory agents; multiple sclerosis, antiarthritic agents; rheumatic diseases;osteoporosis, stroke, asthma; glaucoma; screening; catalyzed CaaX protein methylation
07/17/2008US20080171780 Process for Crystallization of Ramipril and Preparation of a Hydrated Form Thereof
07/17/2008US20080171772 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
07/17/2008US20080171771 New Compounds 391
07/17/2008US20080171692 Substituted amides
07/17/2008US20080169755 N,N-bis((9-(4-fluorophenyl-)carbazol-3-yl-)phenylamine; good electrical properties; charge transport capability; fluorescence; phosphorescence; full spectrum of colors, including red, green, blue, and white; OLED/organic light eitters/; high efficiency; low voltage;brightness; durability
07/17/2008US20080169453 Near infrared ray absorbing material and near infrared ray absorbing filter
07/17/2008CA2672190A1 4-(heterocyclyl)alkyl-n-(arylsulfonyl) indole compounds and their use as 5-ht6 ligands
07/16/2008EP1943266A2 5-lipoxygenase-activating protein (flap) inhibitors
07/16/2008EP1943221A1 Piperazine amidines as antiviral agents
07/16/2008EP1943220A2 Novel indole-containing beta agonists, method for producing them and their use as drugs
07/16/2008EP1943219A2 5-lipoxygenase-activating protein (flap) inhibitors
07/16/2008EP1943217A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
07/16/2008EP1942905A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment
07/16/2008EP1942896A2 5-lipoxygenase-activating protein (flap) inhibitors
07/16/2008EP1942886A1 New crystalline form of perindopril erbumine
07/16/2008EP1581492B1 N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
07/16/2008EP1476151B1 1-arylsulfonyl-3-substitued indole and indoline derivates useful in the treatment of central nervous system disorders
07/16/2008EP1392655B1 Potassium channel openers
07/16/2008CN101223139A 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
07/16/2008CN101223138A Carbazole derivative, material for light emitting element, light emitting element and electronic device obtained by using the same
07/16/2008CN101223137A Process for making hydroisoindoline tachykinin receptor antagonists
07/16/2008CN101223136A New benzoheterocyclylethylbenzamide derivatives
07/16/2008CN101223132A Process for the preparation of sulfonamide derivatives
07/16/2008CN101222920A Enhanced indolinone based protein kinase inhibitors
07/16/2008CN101219986A 3-cyanogen radical indole compounds and its synthetic method
07/16/2008CN101219985A N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action
07/16/2008CN101219959A Anthracene derivant, organic compound, illuminating device and electronic equipments
07/16/2008CN100402499C 2-iminopyrrolidine derivatives
07/15/2008US7399886 Hydrogenation of cyanoethylated alcohols, i.e. by reacting an alcohol with meth)acrylonitrile, utilizing an ether or amide solvent that solubilizes byproduct (meth)acrylonitrile and poly(meth)acrylonitrile present in the feedstock or produced during the hydrogenation; kinetics; durability of catalyst
07/15/2008US7399868 4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
07/15/2008US7399780 pyridin-2-yl-1H-indole or pyrimidin-4-yl-1H-indole derivatives; enzyme inhibitor of glycogen synthase kinase-3; treating dementia, Alzheimer's Disease, Parkinson's Disease, amyotrophic lateral sclerosis, corticobasal degeneration, Down syndrome, Huntington's Disease
07/15/2008US7399779 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonists
07/15/2008US7399776 Antiinflamamtory agents; immunology disorders; autoimmune diseases; antiallergens; aids viricides; antiarthritic agents; muscular disorders; Parkinson's disease; Alzheimer's disease; kidney damage
07/15/2008US7399577 Halogenated oxime derivatives and the use thereof
07/15/2008US7399432 Charge transport compositions and electronic devices made with such compositions
07/15/2008CA2315258C Neuroprotective agents
07/15/2008CA2298522C 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b]-indole-1-acetamide derivatives, their preparation and their application in therapy
07/10/2008WO2008083130A2 Amorphous and crystalline form a of carvedilol phosphate
07/10/2008WO2008082488A1 4, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
07/10/2008WO2008082484A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
07/10/2008WO2008048991A3 Organic compounds
07/10/2008WO2008021422A3 Process for the preparation of indolin-2-one derivatives useful as pr modulators
07/10/2008US20080167477 Novel polymorphic forms of carvedilol dihydrogen phosphate and process for preparing the same
07/10/2008US20080167476 intermediates to functionalized indoles, both natural and synthetic which are cytotoxic agents, anticancer and antiviral agents
07/10/2008US20080167468 Silacycle compounds and methods of use thereof
07/10/2008US20080167364 Ramipril-amine salts
07/10/2008US20080167318 Pharmaceutically active pyrrolidine derivatives
07/10/2008US20080167310 Syndrome X, antidiabetic agents; hypoglycemic agents;antilipemic agents; artherosclerosis; cardiovascular disorders
07/10/2008US20080167306 Novel Heteroaryl Derivative
07/10/2008US20080167288 Substituted cyclic hydroxamates as lnhibitors of matrix metalloproteinases
07/10/2008US20080166593 Organic Electroluminescent Devices
07/10/2008CA2673249A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
07/10/2008CA2672701A1 Process for the preparation of 6,6-dimethyl-3-azabicyclo- [3.1.0]- hexane compounds utilizing bisulfite intermediate
07/09/2008EP1940814A1 Piperazine derivatives as antimalarial agents
07/09/2008EP1940789A1 Methods and compounds for preparing cc-1065 analogs
07/09/2008EP1940788A1 1-benzylindole-2-carboxamide derivatives
07/09/2008EP1940787A1 Novel ido inhibitors and methods of use thereof
07/09/2008EP1940296A2 Chemical compounds
07/09/2008EP1794143B1 Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
07/09/2008EP1673084B1 1-2' (1,4'-biperidin-1'-yl)-1-(phenyl)-ethylcyclohexanol derivatives as monoamine reuptake modulators for the treatment of vasomotor symptoms
07/09/2008EP1572648B1 3,6-disubstituted azabicyclo (3.1.0)-hexane derivatives as muscarinic receptor antagonists
07/09/2008CN101215257A Refining of fluvastatin sodium intermediate and preparation method of fluvastatin sodium
07/09/2008CN101215256A 2-methylamino(4,7-dihydroindole) compound, synthetic method and use thereof
07/09/2008CN101214240A Application of indole-2, 3-diketone in preparing antiphlogistic medicament
07/09/2008CN100401194C Organic photoreceptor for electronic photographing, image device and method, and charge migration composition
07/09/2008CN100400529C Fluoro-aromatic organic tetracarboxylic dianhydride and its preparation method and use
07/09/2008CN100400523C Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
07/09/2008CN100400510C Method of separating optically active dihydroxy-heptenoic acid esters
07/09/2008CN100400116C Endoluminal prosthesis comprising a therapeutic agent and its use
07/08/2008US7396941 Method for producing monatin
07/08/2008US7396940 Randomized library of 500-10000 different compounds immobilized on a solid support; biosynthessis by the Suzuki reaction using a platinum catalyst and boronic acid derivative; antagonists against chemoattractant receptors such as chemokine receptors, particularlyCCR6; antiinflammatory agents
07/08/2008US7396853 2-phenyl-3,3,3-trifluoro-2-hydroxy-propionic acid derivatives
07/08/2008US7396844 3-(4-amidinobenzoylamino)-4-[5-amidino-2-(2-carboxy-2-oxoethyl)phenoxy]butanoic acid; anticoagulant; blood coagulation factor X and thrombin inhibitor; cerebral infarction, thrombosis, embolism, transient ischemic attack (TIA) and subarachnoidal hemorrhage (vasospasm); ischemic heart diseases
07/08/2008US7396831 Vanilloid receptor ligands and their use in treatments
07/08/2008US7396830 Piperazine amidines as antiviral agents
07/03/2008WO2008079216A1 Process for preparing (1r,2s,5s)-n-[(1s)-3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2s)-2-[[[(1,1-dimethylethyl)amino]-carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide